|
1
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol.
15:(Suppl 2). ii1–ii56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei J, Gabrusiewicz K and Heimberger A:
The controversial role of microglia in malignant gliomas. Clin Dev
Immunol. 2013:2852462013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta K and Salunke P: Molecular markers
of glioma: An update on recent progress and perspectives. J Cancer
Res Clin Oncol. 138:1971–1981. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hochberg FH, Atai NA, Gonda D, Hughes MS,
Mawejje B, Balaj L and Carter RS: Glioma diagnostics and
biomarkers: An ongoing challenge in the field of medicine and
science. Expert Rev Mol Diagn. 14:439–452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen LL and Carmichael GG: Long noncoding
RNAs in mammalian cells: What, where, and why? Wiley Interdiscip
Rev RNA. 1:2–21. 2010.PubMed/NCBI
|
|
8
|
Jeon Y, Sarma K and Lee JT: New and
Xisting regulatory mechanisms of X chromosome inactivation. Curr
Opin Genet Dev. 22:62–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ørom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Quek XC, Thomson DW, Maag JL, Bartonicek
N, Signal B, Clark MB, Gloss BS and Dinger ME: lncRNAdb v2.0:
Expanding the reference database for functional long noncoding
RNAs. Nucleic Acids Res. 43:D168–D173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bian EB, Ma CC, He XJ, Wang C, Zong G,
Wang HL and Zhao B: Epigenetic modification of miR-141 regulates
SKA2 by an endogenous ‘sponge’ HOTAIR in glioma. Oncotarget.
7:30610–30625. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J
and Xue YX: Long non-coding RNA CASC2 suppresses malignancy in
human gliomas by miR-21. Cell Signal. 27:275–282. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Wang Y, Li J, Zhang Y, Yin H and
Han B: CRNDE, a long-noncoding RNA, promotes glioma cell growth and
invasion through mTOR signaling. Cancer Lett. 367:122–128. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao X, Wang P, Liu J, Zheng J, Liu Y,
Chen J and Xue Y: Gas5 exerts tumor-suppressive functions in human
glioma cells by targeting miR-222. Mol Ther. 23:1899–1911. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Bian EB, He XJ, Ma CC, Zong G, Wang
HL and Zhao B: Epigenetic repression of long non-coding RNA MEG3
mediated by DNMT1 represses the p53 pathway in gliomas. Int J
Oncol. 48:723–733. 2016.PubMed/NCBI
|
|
19
|
Lin A, Li C, Xing Z, Hu Q, Liang K, Han L,
Wang C, Hawke DH, Wang S, Zhang Y, et al: The LINK-A lncRNA
activates normoxic HIF1α signalling in triple-negative breast
cancer. Nat Cell Biol. 18:213–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Le A, Cooper CR, Gouw AM, Dinavahi R,
Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL and Dang
CV: Inhibition of lactate dehydrogenase A induces oxidative stress
and inhibits tumor progression. Proc Natl Acad Sci USA.
107:2037–2042. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mattick JS: The genetic signatures of
noncoding RNAs. PLoS Genet. 5:e10004592009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. 15:R17–R29. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote
cancer metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang K, Sun X, Zhou X, Han L, Chen L, Shi
Z, Zhang A, Ye M, Wang Q, Liu C, et al: Long non-coding RNA HOTAIR
promotes glioblastoma cell cycle progression in an EZH2 dependent
manner. Oncotarget. 6:537–546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han Y, Wu Z, Wu T, Huang Y, Cheng Z, Li X,
Sun T, Xie X, Zhou Y and Du Z: Tumor-suppressive function of long
noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and
inactivation of ERK/MAPK signaling. Cell Death Dis. 7:e21232016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shi M, Cui J, Du J, Wei D, Jia Z, Zhang J,
Zhu Z, Gao Y and Xie K: A novel KLF4/LDHA signaling pathway
regulates aerobic glycolysis in and progression of pancreatic
cancer. Clin Cancer Res. 20:4370–4380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Y, Su D, Zhao L, Zhang D, Xu J, Wan
J, Fan S and Chen M: Different effects of LDH-A inhibition by
oxamate in non-small cell lung cancer cells. Oncotarget.
5:11886–11896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao D, Zou SW, Liu Y, Zhou X, Mo Y, Wang
P, Xu YH, Dong B, Xiong Y, Lei QY, et al: Lysine-5 acetylation
negatively regulates lactate dehydrogenase A and is decreased in
pancreatic cancer. Cancer Cell. 23:464–476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chesnelong C, Chaumeil MM, Blough MD,
Al-Najjar M, Stechishin OD, Chan JA, Pieper RO, Ronen SM, Weiss S,
Luchman HA, et al: Lactate dehydrogenase A silencing in IDH mutant
gliomas. Neuro-oncol. 16:686–695. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cai Z, Zhao JS, Li JJ, Peng DN, Wang XY,
Chen TL, Qiu YP, Chen PP, Li WJ, Xu LY, et al: A combined
proteomics and metabolomics profiling of gastric cardia cancer
reveals characteristic dysregulations in glucose metabolism. Mol
Cell Proteomics. 9:2617–2628. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Crane CA, Austgen K, Haberthur K, Hofmann
C, Moyes KW, Avanesyan L, Fong L, Campbell MJ, Cooper S, Oakes SA,
et al: Immune evasion mediated by tumor-derived lactate
dehydrogenase induction of NKG2D ligands on myeloid cells in
glioblastoma patients. Proc Natl Acad Sci USA. 111:12823–12828.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim J, Han J, Jang Y, Kim SJ, Lee MJ, Ryu
MJ, Kweon GR and Heo JY: High-capacity glycolytic and mitochondrial
oxidative metabolisms mediate the growth ability of glioblastoma.
Int J Oncol. 47:1009–1016. 2015.PubMed/NCBI
|
|
39
|
Fantin VR, St-Pierre J and Leder P:
Attenuation of LDH-A expression uncovers a link between glycolysis,
mitochondrial physiology, and tumor maintenance. Cancer Cell.
9:425–434. 2006. View Article : Google Scholar : PubMed/NCBI
|
